Latest News
Uniform and facility services provider Cintas (NASDAQ:CTAS) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 8.9% year o...
Via StockStory · July 15, 2026
If you are looking for some blue-chip stocks that are worth buying and holding today (and for several years to come), here are three stocks I’d look to add throughout 2026.
Via The Motley Fool · July 15, 2026
Dollar-cost averaging into these four Vanguard ETFs could help you build long-term wealth.
Via The Motley Fool · July 15, 2026
Nebius Group shares fell 6% amid a tech sell-off, but a $1 billion Reflection AI compute deal pushed its contracted backlog to roughly $50 billion, bolstering its neocloud position.
Via MarketBeat · July 15, 2026
The robotic surgery company has posted earnings beats in its past four quarters. Can it make it five in a row?
Via The Motley Fool · July 15, 2026
Lucid has always been an intriguing investment and has boasted well-designed, advanced EVs. But there may be too many challenges stacked against it for investors to buy or hold long-term.
Via The Motley Fool · July 15, 2026
BlackRock (NYSE:BLK) executives said the asset manager delivered record second-quarter results and its strongest first half on record, driven by broad-based client inflows, higher markets, acquisitions and continued demand for ETFs, private markets and technology offerings.
Chief Financial Officer
Via MarketBeat · July 15, 2026
Conagra Brands (NYSE:CAG) reported fourth-quarter fiscal 2026 results that were within its original full-year guidance ranges, while newly appointed CEO John Brase outlined a plan to restore margins, increase investment and simplify the packaged foods company’s operations.
Brase, speaking on his fi
Via MarketBeat · July 15, 2026
Fractyl Health (NASDAQ:GUTS) reported one-year data from the randomized midpoint cohort of its REMAIN-1 study, saying its Revita procedure helped patients maintain a larger share of GLP-1-induced weight loss after discontinuing GLP-1 therapy compared with a sham procedure.
On the company’s data cal
Via MarketBeat · July 15, 2026
If you want to know the tech sector's priorities, follow the money.
Via The Motley Fool · July 15, 2026
Retention rates remain high despite the fee hike.
Via The Motley Fool · July 15, 2026
Today's moviegoers expect more than just a great film. They also want quick, convenient, and hassle-free food and beverage service. Long concession lines o
Via Talk Markets · July 15, 2026
IntroductionHealthcare organizations need effective financial processes to maintain smooth operations and provide quality patient care. Managing billing, c
Via Talk Markets · July 15, 2026
US stocks traded higher with Dow up 150 points. Consumer discretionary shares surged 1.3% while health care stocks fell 0.4%. Morgan Stanley beat earnings.
Via Benzinga · July 15, 2026
Eye injuries require prompt attention and expert care. Dr. Lalit Kumar provides personalized treatment using advanced techniques for complex eye conditions
Via Talk Markets · July 15, 2026
Inside today’s electronic digital planet, on the web programs demand basic and also protected accessibility methods to aid people control their particular
Via Talk Markets · July 15, 2026
Merck stock popped Wednesday on the back of positive test results for a new treatment combo in a common form of lung cancer.
Via Investor's Business Daily · July 15, 2026
China's electric taxi and rideshare boom is cutting oil demand and reducing fuel prices, as more passengers opt for cheaper app-based trips.
Via Benzinga · July 15, 2026
Jewelry has always been a reflection of personal style, culture, and creativity. As fashion continues to evolve, modern women are choosing accessories that
Via Talk Markets · July 15, 2026
Renewed Iran-U.S. tensions have pushed oil prices and energy stocks higher, with the Vanguard Energy ETF (VDE) and iShares Global Energy ETF (IXC) both rallying off their July 1 lows.
Via MarketBeat · July 15, 2026
The House of Mouse has been a disappointing investment, with the stock down 47% in the past five years.
Via The Motley Fool · July 15, 2026
Benjamin Cowen says Bitcoin's rebound above $64,000 after a softer U.S. inflation report still fits the 2018 bear market pattern rather than signaling a new bull market.
Via Benzinga · July 15, 2026
Johnson & Johnson beats Q2 2026 Wall Street estimates and raises full-year guidance as sales top $25B, driven by oncology and MedTech.
Via Benzinga · July 15, 2026
The medical technology company reported a notable insider sale in recent filings.
Via The Motley Fool · July 15, 2026
PPI fell 0.3% in June, the softest since April 2025. Gold miners, BlackRock and Bank of Nova Scotia topped the large-cap pre-market board. Here's why.
Via Benzinga · July 15, 2026
